Report Detail
(Post-pandemic Era)-Global The Glucagon Like Peptide-1 (GLP-1) Agonists Market Segment Research Report 2021
- RnM3726389 |
- 01 November, 2021 |
- Global |
- 80 Pages |
- XYZResearch |
- Pharma & Healthcare
Summary
The global economy is expected to expand 5.6% in 2021，global recovery is strong but uneven as many emerging market and developing economies continue to struggle with the COVID-19 pandemic, the world is unlikely to ever reach global herd immunity. However, the recovery in many countries is being held back by a resurgence of COVID-19 cases and lagging vaccination progress, as well as the withdrawal of policy support in some instances.
The annual U.S. economic growth rate slipped to -3.5% in 2020, but grew at a yearly pace of more than 6% in the previous two quarters of 2021. The economy of continental Europe bounced back in the second quarter after having contracted in both the fourth quarter of 2020 and the first quarter of 2021, as the vaccinations accelerated, and governments eased restrictions. Among major economies, the annualized growth rate was 6.1% in Germany, 3.6% in France, 11.2% in Italy, and 11.7% in Spain. The especially rapid growth in Spain and Italy was attributed to a surge in consumer spending, likely the result of an easing of economic restrictions.
Regional Economic Prospects: Growth in the East Asia and Pacific is projected to accelerate by 7.7% in 2021, Central Asia is forecast to grow by 3.9% this year, economic activity in the Middle East and North Africa is forecast to advance by 2.4%, South Asia is projected to expand by 6.8%.
The global The Glucagon Like Peptide-1 (GLP-1) Agonists market size was USD XX billion in 2021. It is likely to progress at a CAGR of XX% during the forecast period of 2022-2027, according to XYZResearch analysis, The segment in The Glucagon Like Peptide-1 (GLP-1) Agonists market is estimated to reach a market value of USD XX billion by 2021 from an initial market value of USD XX billion in 2021. China market value in 2021 is about USD XX billion, and China The Glucagon Like Peptide-1 (GLP-1) Agonists production is XX (K Units). US market value in 2021 is about USD XX billion, and US The Glucagon Like Peptide-1 (GLP-1) Agonists production is XX (K Units). Europe market value in 2021 is about USD XX billion, and Europe The Glucagon Like Peptide-1 (GLP-1) Agonists production is XX (K Units).
Regional Segmentation (Value; Revenue, USD Million, 2017 - 2027) of The Glucagon Like Peptide-1 (GLP-1) Agonists Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in The Glucagon Like Peptide-1 (GLP-1) Agonists Market?
Novo Nordisk
GSK
AstraZeneca
Amylin
Eli Lilly
Bristol-Myers Squibb
Sanofi
...
Major Type of The Glucagon Like Peptide-1 (GLP-1) Agonists Covered in XYZResearch report:
Exenatied
Liraglutide
Lixisenatide
Albiglutide
Dulaglutide
Application Segments Covered in XYZResearch Market
Hospital
Pharmacy
Other
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global The Glucagon Like Peptide-1 (GLP-1) Agonists Market Segment Research Report 2021
1. Research Scope
2. Market Overview
- 2.1 Product Introduction, Application, Picture
- 2.2 Global The Glucagon Like Peptide-1 (GLP-1) Agonists Market by Value
- 2.2.1 Global The Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type
- 2.2.2 Global The Glucagon Like Peptide-1 (GLP-1) Agonists Market by Value (%)
- 2.3 Global The Glucagon Like Peptide-1 (GLP-1) Agonists Market by Production
- 2.3.1 Global The Glucagon Like Peptide-1 (GLP-1) Agonists Production by Type
- 2.3.2 Global The Glucagon Like Peptide-1 (GLP-1) Agonists Market by Production (%)
3. The Major Driver of The Glucagon Like Peptide-1 (GLP-1) Agonists Industry
- 3.1 Historical & Forecast Global The Glucagon Like Peptide-1 (GLP-1) Agonists Demand
- 3.2 Largest Application for The Glucagon Like Peptide-1 (GLP-1) Agonists (2017-2027)
- 3.3 The Major Downstream Company in China Market 2021
4. Global and Regional The Glucagon Like Peptide-1 (GLP-1) Agonists Market
- 4.1 Regional Market Size in Terms of Production & Demand (2021)
- 4.2 Regional Market Share in Terms of Revenue (2019-2027)
- 4.3 Concentration Ratio (CR5& CR10) of The Glucagon Like Peptide-1 (GLP-1) Agonists Market
- 4.4 Mergers & Acquisitions, Expansion Plans
5. US The Glucagon Like Peptide-1 (GLP-1) Agonists Production, Demand (2017-2027)
- 5.1 Current and Estimated Production Breakdown by Type
- 5.2 Current and Estimated Demand Breakdown by Type
- 5.3 Current and Estimated Demand Breakdown by Application
- 5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
6. Europe The Glucagon Like Peptide-1 (GLP-1) Agonists Production, Demand (2017-2027)
- 6.1 Current and Estimated Production Breakdown by Type
- 6.2 Current and Estimated Demand Breakdown by Type
- 6.3 Current and Estimated Demand Breakdown by Application
- 6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
7. China The Glucagon Like Peptide-1 (GLP-1) Agonists Production, Demand (2017-2027)
- 7.1 Current and Estimated Production Breakdown by Type
- 7.2 Current and Estimated Demand Breakdown by Type
- 7.3 Current and Estimated Demand Breakdown by Application
- 7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
8. Japan The Glucagon Like Peptide-1 (GLP-1) Agonists Production, Demand (2017-2027)
- 8.1 Current and Estimated Production Breakdown by Type
- 8.2 Current and Estimated Demand Breakdown by Type
- 8.3 Current and Estimated Demand Breakdown by Application
- 8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
9. India The Glucagon Like Peptide-1 (GLP-1) Agonists Production, Demand (2017-2027)
- 9.1 Current and Estimated Production Breakdown by Type
- 9.2 Current and Estimated Demand Breakdown by Type
- 9.3 Current and Estimated Demand Breakdown by Application
- 9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
10. Korea The Glucagon Like Peptide-1 (GLP-1) Agonists Production, Demand (2017-2027)
- 10.1 Current and Estimated Production Breakdown by Type
- 10.2 Current and Estimated Demand Breakdown by Type
- 10.3 Current and Estimated Demand Breakdown by Application
- 10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
11. Southeast Asia The Glucagon Like Peptide-1 (GLP-1) Agonists Production, Demand (2017-2027)
- 11.1 Current and Estimated Production Breakdown by Type
- 11.2 Current and Estimated Demand Breakdown by Type
- 11.3 Current and Estimated Demand Breakdown by Application
- 11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
12. Global The Glucagon Like Peptide-1 (GLP-1) Agonists Average Price Trend
- 12.1 Market Price for Each Type of The Glucagon Like Peptide-1 (GLP-1) Agonists in US (2017-2021)
- 12.2 Market Price for Each Type of The Glucagon Like Peptide-1 (GLP-1) Agonists in Europe (2017-2021)
- 12.3 Market Price for Each Type of The Glucagon Like Peptide-1 (GLP-1) Agonists in China (2017-2021)
- 12.4 Market Price for Each Type of The Glucagon Like Peptide-1 (GLP-1) Agonists in Japan (2017-2021)
- 12.5 Market Price for Each Type of The Glucagon Like Peptide-1 (GLP-1) Agonists in India (2017-2021)
- 12.6 Market Price for Each Type of The Glucagon Like Peptide-1 (GLP-1) Agonists in Korea (2017-2021)
- 12.7 Market Price for Each Type of The Glucagon Like Peptide-1 (GLP-1) Agonists in Southeast Asia (2017-2021)
13. Industrial Chain (Impact of COVID-19)
- 13.1 The Glucagon Like Peptide-1 (GLP-1) Agonists Industrial Chain Analysis
- 13.2 Downstream
- 13.3 Impact of COVID-19
- 13.4 Technology Trends of The Glucagon Like Peptide-1 (GLP-1) Agonists
14. The Glucagon Like Peptide-1 (GLP-1) Agonists Competitive Landscape
- 14.1 Novo Nordisk
- 14.1.1 Novo Nordisk Company Profiles
- 14.1.2 Novo Nordisk Product Introduction
- 14.1.3 Novo Nordisk The Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue (2017-2021)
- 14.1.4 Strategic initiatives
- 14.2 GSK
- 14.2.1 GSK Company Profiles
- 14.2.2 GSK Product Introduction
- 14.2.3 GSK The Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue (2017-2021)
- 14.2.4 Strategic initiatives
- 14.3 AstraZeneca
- 14.3.1 AstraZeneca Company Profiles
- 14.3.2 AstraZeneca Product Introduction
- 14.3.3 AstraZeneca The Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue (2017-2021)
- 14.3.4 Strategic initiatives
- 14.4 Amylin
- 14.4.1 Amylin Company Profiles
- 14.4.2 Amylin Product Introduction
- 14.4.3 Amylin The Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue (2017-2021)
- 14.4.4 Strategic initiatives
- 14.5 Eli Lilly
- 14.5.1 Eli Lilly Company Profiles
- 14.5.2 Eli Lilly Product Introduction
- 14.5.3 Eli Lilly The Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue (2017-2021)
- 14.5.4 Strategic initiatives
- 14.6 Bristol-Myers Squibb
- 14.6.1 Bristol-Myers Squibb Company Profiles
- 14.6.2 Bristol-Myers Squibb Product Introduction
- 14.6.3 Bristol-Myers Squibb The Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue (2017-2021)
- 14.6.4 Strategic initiatives
- 14.7 Sanofi
- 14.7.1 Sanofi Company Profiles
- 14.7.2 Sanofi Product Introduction
- 14.7.3 Sanofi The Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue (2017-2021)
- 14.7.4 Strategic initiatives
15. Conclusion
Summary:
Get latest Market Research Reports on Glucagon like peptide-1 (GLP-1) agonists. Industry analysis & Market Report on Glucagon like peptide-1 (GLP-1) agonists is a syndicated market report, published as (Post-pandemic Era)-Global The Glucagon Like Peptide-1 (GLP-1) Agonists Market Segment Research Report 2021. It is complete Research Study and Industry Analysis of Glucagon like peptide-1 (GLP-1) agonists market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
